Skip to main content
. 2018 Mar 30;9(24):17117–17132. doi: 10.18632/oncotarget.24965

Table 3. Projected absorbed organ doses of 89Zr-DFO-nimotuzumab.

Organ Female – 89Zr absorbed dose (cGy/mCi) Male 89Zr absorbed dose (cGy/mCi)
Adrenals 0.672 0.821
Brain 0.205 0.234
Breasts 0.573 0.601
Gallbladder Wall 1.07 1.30
Lower Large Intestine 0.757 0.779
Small Intestine 0.929 0.954
Stomach 0.693 0.783
Upper Large Intestine 0.882 0.936
Heart Wall 0.601 0.683
Kidneys 0.603 0.775
Liver 1.82 2.64
Lungs 0.481 0.557
Muscle 0.485 0.513
Ovaries 0.656
Pancreas 0.636 0.819
Red Marrow 0.59 0.624
Osteogenic Cells 0.895 0.918
Skin 0.445 0.462
Spleen 0.431 1.93
Testes 0.402
Thymus 0.452 0.473
Thyroid 0.618 0.623
Urinary Bladder 0.639 0.643
Uterus 0.564
Total Body 0.624 0.677
Effective dose (rem/mCi) 0.679 0.757